STOCK TITAN

Nkarta to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical firm focused on engineered NK cell therapies for cancer, announced its participation in several upcoming investor conferences. Notable events include the Cowen 5th Annual IO Next Summit on November 15, 2021, at 11:15 a.m. ET, the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 2:00 p.m. ET, and the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 4:20 p.m. ET. Each session will be webcast live and available for replay on Nkarta's website.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

Cowen 5th Annual IO Next Summit
November 15, 2021
11:15 a.m. ET - fireside chat presentation

Stifel 2021 Virtual Healthcare Conference
November 17, 2021
2:00 p.m. ET – fireside chat presentation

Evercore ISI 4th Annual HealthCONx Conference
December 1, 2021
4:20 p.m. ET – fireside chat presentation

A simultaneous webcast of the presentations will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com


FAQ

What conferences will Nkarta (NKTX) participate in November 2021?

Nkarta will participate in the Cowen 5th Annual IO Next Summit on November 15, 2021, and the Stifel 2021 Virtual Healthcare Conference on November 17, 2021.

What is the date and time of Nkarta's presentation at the Evercore ISI HealthCONx Conference?

Nkarta's presentation at the Evercore ISI 4th Annual HealthCONx Conference is scheduled for December 1, 2021, at 4:20 p.m. ET.

Where can I watch Nkarta's conference presentations?

Nkarta's conference presentations will be available for live webcast and will also be archived on their website for about four weeks.

What is the focus of Nkarta, Inc. (NKTX)?

Nkarta focuses on developing engineered natural killer (NK) cell therapies aimed at treating cancer.

Nkarta, Inc.

NASDAQ:NKTX

NKTX Rankings

NKTX Latest News

NKTX Stock Data

178.19M
70.57M
4.87%
97.1%
14.77%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO